Abingworth Bioventures 8 LP is a venture capital fund based in London, United Kingdom. According to its most recent Form D, filed May 18, 2020, it has sold $132,200,000 of interests to 13 investors since its first sale in May 2020. The filing does not set a minimum investment. It relies on the Section 3(c)(7) exclusion, so investors generally must be qualified purchasers. The offering uses Rule 506(b), which does not permit general solicitation. Related persons named in the filing include Abingworth LLP; Abingworth Bioventures 8 GP LP.
- Total raised
- $132,200,000Cumulative sales reported on Form D
- Investors
- 13
- First sale
- May 11, 2020
- Minimum investment
- None set
- Who can invest
- Qualified purchasersSection 3(c)(7): generally $5M+ in investments
- Offering exemption
- Rule 506(b)No general advertising
- Key people and entities
- Abingworth LLP; Abingworth Bioventures 8 GP LP
- Latest Form D
- May 18, 2020
From SEC filings, not verified. This page republishes the fund's Form D as filed. It is not an offer, solicitation or recommendation, and AltMountain has not reviewed the fund. “Raised” is cumulative sales, not current assets or performance. Returns are not part of SEC filings. Private funds are speculative, illiquid and generally limited to accredited investors or qualified purchasers. Full disclosures · Request a correction
Foundations that report holding this fund
| Foundation | State | Value reported | Basis | Tax year ended |
|---|---|---|---|---|
| Geraldine R Dodge Foundation Inc | NJ | $848,316 | fair market value | Dec 31, 2024 |
1 private foundation listed this fund by name among the investments on its IRS Form 990-PF. The value is the year-end figure the foundation reported, exactly as filed (fair market value where given, otherwise book value); holdings may have changed since, and other investors in the fund are not listed. Matched by the fund's full name; not verified by AltMountain or by the fund. Source: Internal Revenue Service, Form 990 series e-file data.
Questions about Abingworth Bioventures 8 LP
What is the minimum investment for Abingworth Bioventures 8 LP?
Abingworth Bioventures 8 LP's latest Form D, filed May 18, 2020, does not set a minimum investment. Managers can still require one in the offering documents.
Who can invest in Abingworth Bioventures 8 LP?
Abingworth Bioventures 8 LP is generally open only to qualified purchasers (generally individuals with at least $5 million in investments), because it relies on Section 3(c)(7). It uses Rule 506(b), which does not allow general advertising.
How much has Abingworth Bioventures 8 LP raised?
Abingworth Bioventures 8 LP reports $132,200,000 sold from 13 investors on its Form D filed May 18, 2020. This is cumulative sales since the offering began, not current assets or performance.
Where is Abingworth Bioventures 8 LP based?
Abingworth Bioventures 8 LP is based in London, United Kingdom.
When did Abingworth Bioventures 8 LP launch?
Abingworth Bioventures 8 LP reports its first sale in May 2020.
Size compared with every venture capital fund
Raised more than 91% of the 43 venture capital funds based in United Kingdom, and more than 98% of all 14,864 that report sales.